Intracerebral administration of brain-derived neurotrophic factor (BDNF) reduces severity of cataleptic freezing in mice with genetic predisposition to catalepsy

Bulletin of Experimental Biology and Medicine

Volumn 148, Issue 6, 2009, Pages 889-891

  Tikhonova, M A ^a   Kulikov, A V ^a   Naumenko, V S ^a   Morozova, M V ^a   Bazovkina, D V ^a   Popova, N K ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

brain derived neurotrophic factor (BDNF); catalepsy; forced swimming test; Mouse

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR MODIFICATION; CATALEPSY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FORCED SWIMMING TEST; GENETIC PREDISPOSITION; LATERAL BRAIN VENTRICLE; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATALEPSY; MALE; MICE;

ANIMALIA; MUS;

EID: 77954425445     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-010-0844-0     Document Type: Article

References (15)

1. DV Bazovkina AV Kulikov EM Kondaurova, et al. 2005 Genetika 41 9 1222 1228 1:STN:280:DC%2BD2MrmtlyqsA%3D%3D 16240633
2. MA Tikhonova EL Alperina TG Tolstikova, et al. 2009 Zhurn. Vyssh. Nerv. Deyat. 59 2 237 244 1:CAS:528:DC%2BD1MXms1Sltrc%3D
3. MA Tikhonova VV Lebedeva AV Kulikov, et al. 2006 Bull. Eksper. Biol. 141 1 53 55 10.1007/s10517-006-0092-5
4. P Blier C de Montigny 1994 Trends Pharmacol. Sci. 15 7 220 226 10.1016/0165-6147(94)90315-8 1:CAS:528:DyaK2cXlvFClurw%3D 7940983
5. L Cervo A Canetta E Calcagno, et al. 2005 J. Neurosci. 25 36 8165 8172 10.1523/JNEUROSCI.1816-05.2005 1:CAS:528:DC%2BD2MXhtVaktL%2FI 16148224
6. RS Duman 2002 Eur. Psychiatry 17 Suppl. 3 306 310 10.1016/S0924-9338(02) 00654-5 15177086
7. BA Hoshaw JE Malberg I Lucki 2005 Brain Res. 1037 1-2 204 208 10.1016/j.brainres.2005.01.007 1:CAS:528:DC%2BD2MXitleqtrs%3D 15777771
8. AV Kulikov DF Avgustinovich VG Kolpakov, et al. 1995 Pharmacol. Biochem. Behav. 50 3 383 387 10.1016/0091-3057(94)00280-V 1:CAS:528:DyaK2MXjvFKrtrs%3D 7617676
9. AV Kulikov DV Bazovkina EM Kondaurova NK Popova 2008 Genes Brain Behav. 7 4 506 512 10.1111/j.1601-183X.2008.00387.x 1:CAS:528:DC%2BD1cXnvVOit7k%3D 18194468
10. AV Kulikov MA Tikhonova VA Kulikov 2008 J. Neurosci. Methods 170 2 345 351 10.1016/j.jneumeth.2008.01.024 18342949
11. HY Lee YK Kim 2008 Neuropsychobiology 57 4 194 199 10.1159/000149817 1:CAS:528:DC%2BD1cXhtFKjtbvM 18679038
12. M Nibuya S Morinobu RS Duman 1995 J. Neurosci. 15 11 7539 7547 1:CAS:528:DyaK2MXptlOmsLk%3D 7472505
13. Z Rogoz G Skuza B Legutko 2005 J. Physiol. Pharmacol. 56 4 661 671 1:CAS:528:DC%2BD28XnvVansQ%3D%3D 16391422
14. Y Shirayama AC Chen S Nakagawa, et al. 2002 J. Neurosci. 22 8 3251 3261 1:CAS:528:DC%2BD38XjtF2gtLw%3D 11943826
15. P Willner 1990 Pharmacol. Ther. 45 3 425 455 10.1016/0163-7258(90)90076-E 1:CAS:528:DyaK3cXitlejtLY%3D 2405444